HOME >> BIOLOGY >> NEWS
Researchers call for expanding the repertoire in studying birdsong

A pair of leading scientists who study songbirds as models for understanding the human brain and how humans acquire language say it's time for the burgeoning field to begin singing a different tune and study a wider variety of species.

Michael Beecher and Eliot Brenowitz, University of Washington professors of psychology and biology, say that while a great deal of knowledge has been gleaned by studying songbirds over the past three decades, a narrow focus on just a few species only provides a fragmentary picture of how the brains of nearly 4,000 songbird species function.

Writing in companion papers in the March issues of the journals Trends in Neurosciences and Trends in Ecology and Evolution, the two UW scientists argue that there is much greater diversity in how and when birds learn to sing than is generally recognized. They say the value of the birdsong system as a model for studying how the brain controls the learning of language would be greatly enhanced by taking into account the diversity seen among different bird species.

"We are interested in comparative approaches," said Beecher, who is an animal behaviorist. "There are many patterns of learning, but most studies are on zebra finches or white-crowned sparrows, in which song learning is restricted to the first year of life. People are not taking advantage of the wide spectrum of bird species. There probably are more species learning songs into their third and fourth years than those who only learn in the first few months or first year."

"One of the great things about songbirds is there is great variety in the manner in which different species learn to sing," said Brenowitz, a neurobiologist. "They are great models, but we should take advantage of the diversity of what they have to offer."

Brenowitz noted that the often-studied zebra finch is sexually mature in just 90 days.

"They learn song quickly so it is hard to say this change in the brain is related to this asp
'"/>

Contact: Joel Schwarz
joels@u.washington.edu
206-543-2580
University of Washington
24-Mar-2005


Page: 1 2 3

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers identify genetic mutation that may alter tumor cell proliferation
9. Researchers discover method for identifying how cancer evades the immune system
10. Researchers use adult stem cells to create soft tissue
11. Researchers find gene that spurs development of the epididymis

Post Your Comments:
(Date:3/19/2015)... OXFORD, Conn. , March 19, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce market, ... featured in a news clip that aired this week on ... http://www.myfoxdc.com/ ) . In a segment "The Next ... smart wallet ,a new way to pay, and ,a really ...
(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation (OTCQX: ... exhibition for service robots ever held in ... place on May 11-13, 2015 at the Javits ... for the event include: Acorn Product Development; Axis ... Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya Systems ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... /CNW/ - A new national Labour Market Information (LMI) ... profiles of new graduates entering the biotech sector. The ... for New Grads in Biotech," is sponsored in part ... (Rx&D) and features data collected from new graduates that ... from 2013 to 2015. Among the interesting ...
(Date:3/30/2015)... N.J. , March 30, 2015  Naldemedine, ... under development by Shionogi & Co., Ltd., met ... III study (COMPOSE I) for the treatment of ... non-cancer pain receiving opioid therapy. Study results showed ... statistically significantly improved the frequency of spontaneous bowel ...
(Date:3/29/2015)... , March 29, 2015 Caris ... important study data showing the presence of ... gynecologic cancer samples. Using Caris Molecular Intelligence®, ... researchers identified expression of programmed cell death ... of histology while its ligand (PD-L1) expression ...
(Date:3/27/2015)... March 27, 2015  Neogen Corporation (NASDAQ: NEOG ... a prearranged trading plan in accordance with Securities and ... and CEO of Neogen Corporation, is a minority owner ... common stock. Herbert does not have control ... The filing is only for a portion of the ...
Breaking Biology Technology:New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2
Cached News: